Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc.
Inmune Bio, Inc.
M.D. Anderson Cancer Center
Stemline Therapeutics, Inc.
University of Florida
Eisai Inc.
Inmune Bio, Inc.
TVAX Biomedical
TVAX Biomedical
National Cancer Institute, Naples
Cedars-Sinai Medical Center
Takeda
Capital Medical University
Capital Medical University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Bracco Diagnostics, Inc
M.D. Anderson Cancer Center
Bracco Diagnostics, Inc
DNAtrix, Inc.
M.D. Anderson Cancer Center
AbbVie
Bracco Diagnostics, Inc
BBB-Therapeutics B.V.
Dana-Farber Cancer Institute
Neurologix, Inc.